Interpace Biosciences Alpha and Beta Analysis
| IDXGDelisted Stock | USD 2.20 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Interpace Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Interpace Biosciences over a specified time horizon. Remember, high Interpace Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Interpace Biosciences' market risk premium analysis include:
Beta (3.02) | Alpha 3.08 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Interpace |
Interpace Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Interpace Biosciences market risk premium is the additional return an investor will receive from holding Interpace Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Interpace Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Interpace Biosciences' performance over market.| α | 3.08 | β | -3.02 |
Interpace Biosciences Fundamentals Vs Peers
Comparing Interpace Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Interpace Biosciences' direct or indirect competition across all of the common fundamentals between Interpace Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Interpace Biosciences or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Interpace Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Interpace Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Interpace Biosciences to competition |
| Fundamentals | Interpace Biosciences | Peer Average |
| Return On Equity | -2.85 | -0.31 |
| Return On Asset | -0.26 | -0.14 |
| Profit Margin | (0.59) % | (1.27) % |
| Operating Margin | (0.28) % | (5.51) % |
| Current Valuation | 11.72 M | 16.62 B |
| Shares Outstanding | 4.27 M | 571.82 M |
| Shares Owned By Insiders | 28.12 % | 10.09 % |
Interpace Biosciences Opportunities
Interpace Biosciences Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Interpace Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Interpace or other otcs. Alpha measures the amount that position in Interpace Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Interpace Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Interpace Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Interpace Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Interpace Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Interpace Biosciences. Please utilize our Beneish M Score to check the likelihood of Interpace Biosciences' management manipulating its earnings.
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Interpace Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Interpace OTC Stock
If you are still planning to invest in Interpace Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Interpace Biosciences' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |